Morcellation is a surgical technique used to cut large pieces of tissue into smaller fragments so they can be removed through tiny incisions during minimally invasive surgery. It is most commonly performed during gynecological procedures to remove uterine fibroids or the uterus itself. The technique allows surgeons to avoid large abdominal incisions, but it carries a specific risk: if undetected cancer is present in the tissue, morcellation can spread cancerous cells inside the body.
How Morcellation Works
During laparoscopic surgery, instruments are inserted through incisions typically 2 centimeters or smaller. That’s fine for a camera or a scalpel, but a uterine fibroid or an entire uterus won’t fit through a hole that size. Morcellation solves this by breaking the tissue down inside the body so it can be pulled out piece by piece.
There are two main approaches. Power morcellation uses an electromechanical device, essentially a rotating blade, inserted through one of the small incisions to shred tissue into strips or chunks inside the abdominal cavity. Manual morcellation involves placing the tissue into a retrieval bag, pulling part of the bag out through an incision, and cutting the tissue apart with a scalpel or scissors by hand. The manual approach is slower but gives the surgeon more control over where the tissue fragments end up.
When Surgeons Use It
Morcellation is used primarily in two gynecological surgeries: laparoscopic myomectomy (removing fibroids while preserving the uterus) and laparoscopic hysterectomy (removing the uterus entirely). Many women with symptomatic fibroids who want a minimally invasive approach will need some form of morcellation, because fibroids can grow quite large, sometimes the size of a grapefruit or bigger.
Not every patient is a candidate. The FDA specifically recommends against power morcellation for women who are postmenopausal or over 50, and for women whose tissue can be removed intact through the vagina or a small abdominal incision (called a minilaparotomy). These guidelines exist because the risk of hidden cancer increases with age, and because alternative extraction methods are available for many patients.
The Hidden Cancer Risk
The core concern with morcellation is something called occult cancer, meaning cancer that can’t be detected before surgery. Uterine fibroids are almost always benign, but in rare cases what appears to be a fibroid on imaging is actually a leiomyosarcoma, a type of uterine cancer. No reliable test can distinguish between the two before surgery.
A large meta-analysis of 134 studies estimated that roughly 1 in 2,000 women undergoing fibroid surgery have an undetected leiomyosarcoma. When the analysis was limited to higher-quality prospective studies, the rate dropped to about 1 in 8,300. Those numbers sound small, but the consequences are severe: if a morcellator shreds cancerous tissue inside the abdomen, it can scatter cancer cells across the peritoneal cavity, potentially advancing the disease from a localized tumor to widespread cancer and significantly reducing survival.
Even with benign tissue, uncontained morcellation can cause problems. Tiny fragments of uterine tissue left behind in the abdomen can implant on surrounding organs and grow into what are called parasitic myomas or, in rarer cases, a condition called disseminated peritoneal leiomyomatosis. These complications can require additional surgeries down the line.
How Contained Morcellation Reduces Risk
In response to safety concerns, the FDA now recommends that when power morcellation is appropriate, it should only be performed with a tissue containment system. This is essentially a specially designed surgical bag placed inside the abdomen. The tissue is morcellated inside the bag, which is intended to prevent fragments from escaping into the abdominal cavity.
The containment system must be legally marketed in the United States and compatible with the specific morcellator being used. While the concept is straightforward, research on long-term effectiveness is still limited. Studies have not yet produced enough data to draw firm conclusions about whether contained morcellation fully prevents complications like parasitic fibroids or tissue fragment implantation. It is, however, a meaningful improvement over the older practice of uncontained power morcellation, where tissue was shredded freely inside the abdomen.
FDA Recommendations and Labeling
The FDA first issued a safety communication discouraging power morcellation in 2014, and has updated its guidance several times since. In December 2020, the agency finalized labeling requirements for laparoscopic power morcellators, ensuring that both patients and surgeons are clearly informed about the risks.
The current FDA position includes several key points. Power morcellators should never be used when tissue is known or suspected to contain cancer. Surgeons must inform patients about the risk of occult cancer and explain that morcellation could spread undetected malignancy. The agency also notes that cancer risk, particularly for uterine sarcoma, increases with age, especially in women over 50. For patients who can have tissue removed intact, either vaginally or through a minilaparotomy, those routes are preferred.
Recovery Compared to Open Surgery
The reason morcellation exists at all is that minimally invasive surgery offers real recovery advantages. In one study comparing laparoscopic myomectomy (which uses morcellation) to minilaparotomy (a small open incision), the laparoscopic group had a median hospital stay of just 5 hours compared to 23 hours for the open approach. Patients who undergo laparoscopic procedures generally return to normal activities within two to four weeks, while open abdominal surgery typically requires four to six weeks of recovery.
The tradeoff is operating time. Laparoscopic procedures with morcellation tend to take longer in the operating room. But for many patients, the shorter hospital stay, smaller scars, and faster return to daily life make the minimally invasive route worthwhile, provided they are appropriate candidates and the risks have been clearly discussed.
Questions to Consider Before Surgery
If your surgeon recommends a procedure that involves morcellation, there are practical things worth understanding. Ask whether your tissue can be removed intact through the vagina or a small incision instead. Ask whether a containment system will be used. Find out what imaging has been done to evaluate the tissue and whether there are any features that raise concern for malignancy.
Your age, menopausal status, the size and number of fibroids, and whether you want to preserve your uterus all factor into which approach makes sense. There is no single right answer. The goal is to balance the real benefits of minimally invasive surgery against the small but serious risk of spreading undetected cancer.